Parkman Healthcare Partners LLC Reviva Pharmaceuticals Holdings, Inc. Call Options Transaction History
Parkman Healthcare Partners LLC
- $770 Million
- Q1 2025
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding RVPH
# of Institutions
56Shares Held
7.42MCall Options Held
938KPut Options Held
62.1K-
Vanguard Group Inc Valley Forge, PA1.8MShares$847,9230.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.53MShares$721,1280.0% of portfolio
-
Diadema Partners LP Morristown, NJ651KShares$305,8390.16% of portfolio
-
Tang Capital Management LLC San Diego, CA510KShares$239,8540.03% of portfolio
-
Geode Capital Management, LLC Boston, MA419KShares$196,9950.0% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $9.61M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...